Dr Reddy’s seeks DCGI approval for Phase 3 clinical trials of Sputnik V in India
The Indian pharma company has partnered with RDIF to conduct clinical trials Russian COVID-19 vaccine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
The formula to step up India Nutra Inc’s success
A synopsis of the prerequisites for India Nutra Inc in its next leg of growth
Panacea Biotec completes Phase I/II study of DengiAll, a tetravalent dengue vaccine candidate
The company has approached DGCI to seek accelerated review of its data to bring DengiAIl to market quickly
Bayer gets DCGI nod for intravitreal aflibercept injection, Eylea to treat diabetic macular edema
Intravitreal Aflibercept is administered via injection directly in the area of swelling in the eye
Serum Institute receives DCGI approval to resume trials of Oxford COVID-19 vaccine
The DCGI has, however, put certain conditions like taking extra care during screening, providing additional information in…
PNB Vesper gets DCGI nod to test proprietary drug PNB 001 in COVID-19 patients
A study will be conducted on 40 moderately-ill COVID-19 patients at BMJ Medical College, Pune who are on oxygen support
SII pauses trials of COVID-19 vaccine candidate Covishield in India
The company took this step after the DCGI issued a show cause notice to the company for not informing it about AstraZeneca…
DCGI instructs industry to follow defined pathways for application submission of rational FDCs
It gives six months to the manufacturers to submit the applications
DCGI issues notice to Serum Institute over AstraZeneca-Oxford COVID-19 vaccine trial suspension
If DCGI has any safety concerns, we will follow their instructions and abide by the standard protocol, said SII in response to…
Bharat Biotech gets DCGI nod for PHASE II trials of COVAXIN
The subject expert committee (SEC) has recommended that the trial will be conducted on 380 participants